Alembic Pharmaceuticals Receives USFDA Final Approval for Valganciclovir Oral Solution
Alembic Pharmaceuticals received USFDA final approval for valganciclovir oral solution 50 mg/mL.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Alembic Pharmaceuticals received USFDA final approval for valganciclovir oral solution 50 mg/mL.